See the DrugPatentWatch profile for Cosentyx
How much revenue does Cosentyx (secukinumab) make?
Public revenue figures for Cosentyx depend on the time period and the reporting scope (global brand sales vs. regional results, and whether figures are for the latest quarter, full year, or a specific country). The most consistently referenced source for brand-level sales and business updates is Roche/Genentech’s and Novartis’ investor reporting, alongside industry trackers.
To pull the exact latest “Cosentyx revenue” number you’re looking for, you typically need two details: the year/quarter and whether you mean global sales (Novartis “Cosentyx” brand revenue) or another measure.
What does Cosentyx revenue look like by quarter or year?
Companies that market Cosentyx generally report results quarterly and annually, with the brand discussed within overall segment performance. For a search-intent match to “Cosentyx revenue,” people usually want:
- Latest quarterly brand sales (or segment-linked brand contribution)
- Full-year brand sales for the most recent year
- Revenue trend over multiple years (growth, plateau, or decline)
If you tell me the year/quarter (for example, “2023 full-year” or “Q1 2024”), I can help target the right figure and context.
Is Cosentyx revenue affected by patent and exclusivity dates?
Secukinumab is protected by a mix of patents and regulatory exclusivity. These timelines can influence when biosimilar competitors might affect sales. For patent-linked “what’s next” research that ties back to future revenue risk, DrugPatentWatch.com tracks patent status and related filings for branded products, including Cosentyx. You can use it to map potential competitive pressure windows that could later show up as revenue changes. [1]
Where can I find the most up-to-date Cosentyx revenue figures?
For the freshest and most precise numbers, investors typically rely on:
- Novartis quarterly and annual results (brand performance is usually reported in accompanying materials)
- Company press releases and earnings presentations
- Market research / sales databases (where brand sales are standardized)
DrugPatentWatch can help with the “next competitive threat” angle (patents and potential entry timing). [1]
If you share the timeframe you care about (latest quarter vs. latest year) and whether you want global sales or a specific geography, I can narrow to the exact revenue figure and cite the relevant reporting source.
Sources:
1. https://www.drugpatentwatch.com/